FA
TDOC icon

Friess Associates’s Teladoc Health TDOC Stock Holding History

Friess Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-137,303
Closed -$9.12M – 132
2019
Q2 		$9.12M Sell
137,303
-86,560
-39% -$5.04M 0.67% 62
2019
Q1 		$12.4M Buy
+223,863
New +$13.7M 0.91% 54
2018
Q2 		– Sell
-77,316
Closed -$3.12M – 140
2018
Q1 		$3.12M Sell
77,316
-219,166
-74% -$8.27M 0.25% 82
2017
Q4 		$10.3M Buy
296,482
+3,893
+1% +$129K 0.86% 59
2017
Q3 		$9.7M Buy
292,589
+275,297
+1,592% +$9.03M 0.85% 61
2017
Q2 		$600K Buy
17,292
+1,149
+7% +$33.5K 0.05% 102
2017
Q1 		$404K Buy
+16,143
New +$336K 0.04% 106
2015
Q4 		– Sell
-5,000
Closed -$111K – 180
2015
Q3 		$111K Buy
+5,000
New +$135K 0.01% 141

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Friess Associates's TDOC Position: Q3 2019 in Review

Friess Associates sold out of Teladoc Health (TDOC) in Q3 2019, closing a stake of 137,303 shares — an estimated $9.12M sold.

Friess Associates first reported a position in TDOC in Q3 2015 and held it in 8 quarters. The position peaked at $12.4M in Q1 2019. 378 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Friess Associates reported no remaining Teladoc Health position as of Q3 2019 after selling out during the quarter.
  • Friess Associates sold 137,303 Teladoc Health shares in Q3 2019, an estimated $9.12M.
  • Friess Associates first reported a position in Teladoc Health in Q3 2015 and held it in 8 quarters.
  • Friess Associates's Teladoc Health position peaked at $12.4M in Q1 2019.
  • 378 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Friess Associates's 13F filing for Q3 2019, filed 14 Nov 2019.